Role of LuCE in GUIDE.MRD
In a rapidly changing scenario in which accurate, early and precise diagnosis is becoming a major game-changer in lung cancer, GUIDE.MRD represents a true valuable opportunity to improve the outcomes for patients and, at the same time, being able to incorporate the patient preferences and needs in this regard.
Why does LuCE participate in the GUIDE.MRD project?
As member of the GUIDE.MRD consortium, together with Digestive Cancers Europe (DiCE) and led by The Synergist, LuCE is truly committed to contribute in a productive continuous way to ensure the best outcomes for everyone impacted by the disease.
LuCE Principal Investigator involved in GUIDE.MRD
